DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines
- PMID: 2648255
DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines
Abstract
The nuclear proto-oncogene c-myc is believed to play a regulatory role in eukaryotic cellular growth and differentiation. Several studies have demonstrated rapid down-regulation of the steady-state levels of c-myc RNA during DMSO induced differentiation of the human 'promyelocytic' cell line, HL-60. However, little is known about the effect of DMSO on c-myc regulation in cells which are not induced to differentiate by DMSO. We have examined the effect of DMSO on c-myc RNA levels in a number of cell lines with different lesions in the c-myc gene, including those which do not differentiate in response to DMSO treatment. Here we demonstrate that DMSO induces a rapid, but transient, reduction in the steady-state level of c-myc RNA in human 'erythroid' K562 cells, Burkitt lymphoma lines Daudi and Raji, human T cell lymphoblastoid line CEM and mouse lymphoma line L1210. However, DMSO treatment does not produce a similar effect in the human colon adenocarcinoma cell line COLO 320 or HeLa epithelial cervical carcinoma cells. These observations demonstrate that the DMSO induced modulation of c-myc RNA levels is a more common phenomenon than previously recognised, and is not necessarily correlated with either the induction of cellular differentiation or growth arrest.
Similar articles
-
Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.Cancer Res. 1989 Oct 1;49(19):5329-33. Cancer Res. 1989. PMID: 2670202
-
Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.Oncogene. 1990 Aug;5(8):1247-50. Oncogene. 1990. PMID: 1697411
-
Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.Nature. 1986 Aug 21-27;322(6081):748-50. doi: 10.1038/322748a0. Nature. 1986. PMID: 3528861
-
Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.Oncogene. 1992 Sep;7(9):1817-25. Oncogene. 1992. PMID: 1323820
-
The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).Anticancer Res. 1989 Sep-Oct;9(5):1265-79. Anticancer Res. 1989. PMID: 2686529 Review.
Cited by
-
c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.Br J Cancer. 1989 Oct;60(4):505-10. doi: 10.1038/bjc.1989.303. Br J Cancer. 1989. PMID: 2572268 Free PMC article.
-
Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase.Biochem J. 2004 Feb 1;377(Pt 3):641-51. doi: 10.1042/BJ20030839. Biochem J. 2004. PMID: 14572310 Free PMC article.
-
Ca2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathways.Biochem J. 1995 Nov 15;312 ( Pt 1)(Pt 1):151-8. doi: 10.1042/bj3120151. Biochem J. 1995. PMID: 7492305 Free PMC article.
-
Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.Br J Cancer. 1992 Jul;66(1):93-8. doi: 10.1038/bjc.1992.223. Br J Cancer. 1992. PMID: 1637683 Free PMC article.
-
Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.Mol Cell Biol. 1990 Aug;10(8):3952-64. doi: 10.1128/mcb.10.8.3952-3964.1990. Mol Cell Biol. 1990. PMID: 2196440 Free PMC article.